Cisplatin nephrotoxicity: new insights and therapeutic implications

C Tang, MJ Livingston, R Safirstein… - Nature Reviews …, 2023 - nature.com
Cisplatin is an effective chemotherapeutic agent for various solid tumours, but its use is
limited by adverse effects in normal tissues. In particular, cisplatin is nephrotoxic and can …

Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications

C Guo, G Dong, X Liang, Z Dong - Nature Reviews Nephrology, 2019 - nature.com
Acute kidney injury (AKI) is a major public health concern associated with high morbidity and
mortality. Despite decades of research, the pathogenesis of AKI remains incompletely …

Inhibition of ACSS2-mediated H3K9 crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence

L Li, T Xiang, Y Wu, H Feng, J Liu, S Tao, F Guo, P Fu… - 2023 - researchsquare.com
Histone lysine crotonylation (Kcr), a novel posttranslational modification, is widespread as
acetylation (Kac); however, its roles are largely unknown. In this study, we report that histone …

[HTML][HTML] Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling

M Liu, K Liang, J Zhen, M Zhou, X Wang… - Nature …, 2017 - nature.com
Podocyte injury is a major determinant of proteinuric kidney disease and the identification of
potential therapeutic targets for preventing podocyte injury has clinical importance. Here, we …

Protein acetylation and deacetylation: An important regulatory modification in gene transcription

C Xia, Y Tao, M Li, T Che, J Qu - Experimental and …, 2020 - spandidos-publications.com
Cells primarily rely on proteins to perform the majority of their physiological functions, and
the function of proteins is regulated by post‑translational modifications (PTMs). The …

Targeting epigenetic DNA and histone modifications to treat kidney disease

M Fontecha-Barriuso, D Martin-Sanchez… - Nephrology dialysis …, 2018 - academic.oup.com
Epigenetics refers to heritable changes in gene expression patterns not caused by an
altered nucleotide sequence, and includes non-coding RNAs and covalent modifications of …

Sirt1 inhibits renal tubular cell epithelial–mesenchymal transition through YY1 deacetylation in diabetic nephropathy

L Du, X Qian, Y Li, X Li, L He, L Xu, Y Liu, C Li… - Acta Pharmacologica …, 2021 - nature.com
Abstract Silent information regulator 1 (Sirt1) is a deacetylase, which plays an important role
in the occurrence and development of diabetic nephropathy (DN). Our previous study shows …

Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells

J Liu, MJ Livingston, G Dong, C Tang, Y Su, G Wu… - Cell death & …, 2018 - nature.com
Histone deacetylase inhibitors (HDACi) have therapeutic effects in models of various renal
diseases including acute kidney injury (AKI); however, the underlying mechanism remains …

[HTML][HTML] Anticancer properties of chitosan against osteosarcoma, breast cancer and cervical cancer cell lines

Z Abedian, AA Moghadamnia, E Zabihi… - Caspian journal of …, 2019 - ncbi.nlm.nih.gov
Background: Cancer is still the most common cause of morbidity in the world. Chitosan, a
commonly used natural polymer, is consisted of different molecular weight with different …

PSTPIP2 inhibits cisplatin-induced acute kidney injury by suppressing apoptosis of renal tubular epithelial cells

H Zhu, W Jiang, H Zhao, C He, X Tang, S Xu, C Xu… - Cell death & …, 2020 - nature.com
Cisplatin (CP) is an effective chemotherapeutic agent widely used in the treatment of various
solid tumours. However, CP nephrotoxicity is an important limitation for CP use; currently …